Approaches to identify kinase dependencies in cancer signalling networks

Maria Dermit1, Arran Dokal1, Pedro R Cutillas1

  • 1Cell Signalling & Proteomics Group, Barts Cancer Institute (CRUK Centre), Queen Mary University of London, UK.

FEBS Letters
|July 11, 2017
PubMed

Insights

New phosphoproteomics methods help identify regulatory kinases and their activation status in cell signaling networks. This approach advances personalized cancer medicine by pinpointing patient-specific targets.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Systems Biology

Background:

  • Cells process external signals via complex biochemical networks.
  • Kinases (protein and lipid) are key regulators in these signaling pathways.
  • Understanding kinase activity is crucial for deciphering cellular responses.

Purpose of the Study:

  • To review experimental and computational approaches for identifying regulatory kinases.
  • To focus on phosphoproteomics-based methods for inferring kinase activation.
  • To highlight the integration of phosphoproteomics with other omics data.

Main Methods:

  • Review of phosphoproteomics-based methodologies.
  • Integration of kinase activity data with other omics datasets (e.g., genomics, transcriptomics).
  • Computational approaches for network analysis and regulatory node identification.

Main Results:

  • Phosphoproteomics enables inference of kinase activation status within signaling networks.
  • Integrating phosphoproteomics with other omics data aids in identifying key regulatory nodes.
  • Emerging methodologies show promise for network-level kinase activity assessment.

Conclusions:

  • Phosphoproteomics is a powerful tool for understanding kinase-driven signaling.
  • Integrated omics approaches enhance the identification of regulatory elements in cellular networks.
  • These advancements pave the way for personalized cancer medicine through target identification.

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
8.8K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.8K
Protein Networks02:26

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.6K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
18.7K